1. Home
  2. OMH vs RVPH Comparison

OMH vs RVPH Comparison

Compare OMH & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

N/A

Current Price

$1.25

Market Cap

28.7M

Sector

Finance

ML Signal

N/A

Logo Reviva Pharmaceuticals Holdings Inc.

RVPH

Reviva Pharmaceuticals Holdings Inc.

HOLD

Current Price

$0.74

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMH
RVPH
Founded
2015
2006
Country
Singapore
United States
Employees
N/A
14
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.7M
29.2M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
OMH
RVPH
Price
$1.25
$0.74
Analyst Decision
Hold
Strong Buy
Analyst Count
1
7
Target Price
N/A
$66.67
AVG Volume (30 Days)
23.9K
2.2M
Earning Date
11-28-2025
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$28.40
N/A
Revenue Next Year
$23.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$0.17
52 Week High
$4.33
$3.11

Technical Indicators

Market Signals
Indicator
OMH
RVPH
Relative Strength Index (RSI) 48.78 43.31
Support Level $1.03 $0.32
Resistance Level $1.37 N/A
Average True Range (ATR) 0.09 0.24
MACD 0.00 -0.18
Stochastic Oscillator 60.98 2.50

Price Performance

Historical Comparison
OMH
RVPH

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: